if i am going to be *quoted* .. show the entire quote ..
btw .. there are no guarantees on any US Equity .. regardless of where traded .. but it has been profitable to learn what NR does .. and how they do it .. :)
it has indeed been profitable learning how NR works cycles of money when it comes to *targets* regardless of where traded ..
PTOI is just one target .. as of today P2O (company) remains an OTC Survivor
when mgmts of OTC targets .. like P2O .. actually execute particularly after years (2009 to today) of NRs' *abuse* .. how *handled* can be epic
it's why *volume* matters .. and this week in particular .. especially so .. :)